Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Goto

Showing results (111-120 of 265) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|June 23, 2017
Anti-Bovine Programmed Death-1 Rat-Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in CattleTomohiro Okagawa, Satoru Konnai, Asami Nishimori, et al.
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 26, 2007
Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanTsutomu Yamazaki, Shinya Goto, Hiroshi Shigematsu, et al.
Archives of Internal Medicine|June 20, 2012
Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosisJacob A Udell, Philippe Gabriel Steg, Benjamin M Scirica, et al.
Archives of Internal Medicine|November 25, 2010
Metformin use and mortality among patients with diabetes and atherothrombosisRonan Roussel, Florence Travert, Blandine Pasquet, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 12, 2012
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairmentMasatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2012
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Circulation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.
Journal of Cardiology|January 23, 2016
Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AFMasatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 29, 2013
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AFNorio Tanahashi, Masatsugu Hori, Masayasu Matsumoto, et al.
Pageof 27

Showing results (111-120 of 265) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|June 23, 2017
Anti-Bovine Programmed Death-1 Rat-Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in CattleTomohiro Okagawa, Satoru Konnai, Asami Nishimori, et al.
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 26, 2007
Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanTsutomu Yamazaki, Shinya Goto, Hiroshi Shigematsu, et al.
Archives of Internal Medicine|June 20, 2012
Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosisJacob A Udell, Philippe Gabriel Steg, Benjamin M Scirica, et al.
Archives of Internal Medicine|November 25, 2010
Metformin use and mortality among patients with diabetes and atherothrombosisRonan Roussel, Florence Travert, Blandine Pasquet, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 12, 2012
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairmentMasatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2012
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Circulation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.
Journal of Cardiology|January 23, 2016
Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AFMasatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 29, 2013
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AFNorio Tanahashi, Masatsugu Hori, Masayasu Matsumoto, et al.
Pageof 27